Sandoz Files Lawsuit against Astellas over Patent for Incontinence Drug
shot by IP News Shots / 9:07 pm on 02 March, 2021
A generic unit of Novartis, Sandoz AG, has filed a lawsuit against Astellas Pharma Inc. intending to revoke its patent for treatment of urinary incontinence. In its high court filing, Sandoz is looking for a declaration by the court that the patent belonging to Astellas is invalid as well as a supplementary protection certificate the company secured to extend its patent rights.
Read more at: https://www.law360.com/articles/1358590/astellas-sued-again-over-incontinence-drug-patent